- info@xaniacorp.com
The Science behind Xtagen
Understanding Inflammation at Its Core
Chronic inflammation is a silent but destructive force. Whether in joints, vascular tissue, or the gut, it is driven by three interlinked biological triggers:
Cytokine Overload
Molecules like IL-6, TNF-α, and NO drive persistent pain, swelling, and tissue degradation.
MAPK Pathway Activation
Key signaling routes (ERK, p38, JNK) amplify the inflammatory cascade by recruiting white blood cells and inducing destructive enzymes.
Oxidative Stress
Free radicals impair healing and accelerate joint, cartilage, and systemic damage.
How Xtagen™ Works
Xtagen™ is powered by Abagen™, a patented marine peptide complex developed in Australia. These bioactive peptides, extracted from abalone, exhibit targeted action on the cellular pathways that drive inflammation, oxidative damage, and vascular stress.
Cytokine Suppression
Xtagen™ reduces the expression and release of:
- Interleukin-6 (IL-6) – a master regulator of chronic inflammation
- Tumor Necrosis Factor-alpha (TNF-α) – involved in pain, cartilage loss, and autoimmune signaling
- Nitric Oxide (NO) – elevated in inflamed synovial tissues and oxidative conditions
Studies demonstrate significant reductions in these markers following Abagen exposure, confirming its potential as a cytokine modulator.
MAPK Pathway Inhibition
The MAPK cascade is a central signaling route in inflammation. Xtagen™ helps:
- Inhibit phosphorylation of ERK1/2, JNK, and p38 kinases
- Prevent leukocyte migration into inflamed tissues
- Downregulate pro-inflammatory gene transcription
This dual action — suppression of messengers + signal blockers — is rare in naturally derived compounds
Antioxidant & Cytoprotective Action
Xtagen™ enhances cellular resilience through:
- Scavenging of reactive oxygen species (ROS)
- Reduction of lipid peroxidation
- Upregulation of intrinsic antioxidant enzymes like SOD and Catalase
This protects joint, cartilage, and vascular tissues from oxidative degradation — a key factor in aging and chronic disease progression.
Anticoagulant Modulation via HCII
Xtagen™ also exhibits unique hemostatic balancing properties:
- Inhibits thrombin activity via Heparin Cofactor II (HCII)
- Prolongs clotting times (PT, aPTT) without increasing bleeding risk
- Supports microvascular circulation in inflamed or ischemic tissues
This makes it especially valuable in managing inflammation-related coagulopathies seen in aging, cardiovascular, and autoimmune conditions.
The Scientific Edge of Xtagen™
What sets Xtagen™ apart is not just what it contains — but how it works:
Multi-target action
IL-6, TNF-α, MAPK, NO, ROS, thrombin
High bioactivity
Peptide-based, water-soluble, structurally stable
Clinically scalable
Compatible with capsule formats, stable in oral delivery
Low interaction risk
Non-pharmaceutical mechanism, safe with other joint support agents
Backed by extensive biochemical screening and mechanistic data, Xtagen™ offers a new paradigm in natural inflammation control. Xtagen™ is powered by Abagen™, a patented marine peptide complex protected under International Patent WO 2017/124149 — ensuring proprietary structure, process, and application.
How Xtagen™ Interrupts the Inflammatory Cascade at the Molecular Level
Chronic inflammation is a silent but destructive force. Whether in joints, vascular tissue, or the gut, it is driven by three interlinked biological triggers:
↓ Up to 67% IL-6 ↓ 55% Synovial IL-6 ↓ Oxidative stress levels
↓ Up to 52%
↓ Downstream
Cytokine Cascade
Migration
↓ 44% leukocyte
adhesion markers
↓ Vascular permeability
& Synovium
↓ 62% cartilage degradation
enzymes
via HCIIM
↑ Prothrombin Time (PT) by 38%
↑ aPTT by 45%
Defense
↑ SOD and Catalase
↓ Oxidative stress –
induced apoptosis
Marine Bioactive
Peptides
Unique sulfated
structure Clinically
validated
bioactivity High oral stability
Defense
Defense
62% cartilage
degradation
enzymes
Reutralizes Nitric Oxide
Global Relevance. Pharma-Grade Innovation.
Xtagen™ is not positioned as a wellness supplement — it is engineered as a natural-origin, mechanism-driven alternative to traditional anti-inflammatories.
Whether in osteoarthritis, sports recovery, or chronic systemic inflammation — Xtagen™ delivers where it matters:
At the root. At the molecular level. With real science
Xania Corporation USA Inc and Southern Ocean Biotech Pty Ltd are the licensed users of the brands Xtagen™ and Abagen™ globally.
All content on this website — including text, graphics, scientific data, and design — is the exclusive intellectual property of Xania Corporation and is protected by international copyright and trademark laws.
Quick Links
© 2025 Xania Corporation USA Inc and its overseas group companies. All rights reserved.